scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1025088004 |
P356 | DOI | 10.1007/BF00295407 |
P698 | PubMed publication ID | 730158 |
P2093 | author name string | Y Nordmann | |
H de Verneuil | |||
G Aitken | |||
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity | Q24634032 | ||
Erythrocyte metabolism. VI. Separation of erythrocyte enzymes from hemoglobin | Q34021614 | ||
Porphyrin metabolism in porphyria cutanea tarda | Q39621964 | ||
Analytical review enzymatic defects of hereditary porphyrias: An explanation of dominance at the molecular level | Q39714566 | ||
Porphyrins and porphyrinogen carboxy-lyase in hexachlorobenzene-induced porphyria | Q42235834 | ||
Identification of a group of tetracarboxylate porphyrins, containing one acetate and three propionate -substituents, in faeces from patients with symptomatic cutaneous hepatic porphyria and from rats with porphyria due to hexachlorobenzene | Q42730308 | ||
Porphyrin biosynthesis. VII. Porphyrinogen carboxy-lyase from avian erythrocytes. Purification and properties | Q55061696 | ||
The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat | Q67755745 | ||
The simultaneous separation and washing of erythrocytes | Q68928283 | ||
Studies of the uroporphyrins. III. An improved method for the decarboxylation of uroporphyrin | Q73399577 | ||
P433 | issue | 2 | |
P921 | main subject | porphyria | Q271759 |
P304 | page(s) | 145-151 | |
P577 | publication date | 1978-10-01 | |
P1433 | published in | Human Genetics | Q5937167 |
P1476 | title | Familial and sporadic porphyria cutanea: two different diseases | |
P478 | volume | 44 |
Q93614889 | A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron |
Q28288050 | A zebrafish model for hepatoerythropoietic porphyria |
Q53259889 | An editor's look-back |
Q70339243 | Assignment of the gene for uroporphyrinogen decarboxylase to human chromosome 1 by somatic cell hybridization and specific enzyme immunoassay |
Q28118865 | Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria |
Q35960885 | Clinical manifestations of hepatitis C. |
Q28367600 | Control of delta-aminolaevulinate synthase and haem oxygenase in chronic-iron-overloaded rats |
Q33738781 | Dermatological manifestations of alcoholic cirrhosis |
Q70609968 | Different types of porphyria cutanea tarda |
Q72576225 | Disodium cromoglycate and the cough reflex |
Q48241013 | Effects of chlorinated organics on intermediates in the heme pathway and on uroporphyrinogen decarboxylase |
Q42070494 | Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria |
Q35035505 | Effects of polyhalogenated aromatic compounds on porphyrin metabolism |
Q35199862 | Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria |
Q24539508 | Familial Porphyria Cutanea Tarda: Characterization of Seven Novel Uroporphyrinogen Decarboxylase Mutations and Frequency of Common Hemochromatosis Alleles |
Q45954724 | Familial porphyria cutanea tarda in Spain: Characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation |
Q62607299 | Genetic hemochromatosis in Italian patients with prophyria cutanea tarda: possible explanation for iron overload |
Q69740094 | Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects |
Q71465393 | HLA and porphyria cutanea tarda |
Q57848536 | HOMOZYGOUS VARIEGATE PORPHYRIA |
Q28367581 | Harderoporphyria: a variant hereditary coproporphyria |
Q41924085 | Hepatic porphyria |
Q43001747 | Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection. |
Q45757982 | Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection |
Q42982870 | Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association |
Q43815439 | Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda |
Q72468695 | Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda? |
Q53778863 | Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication |
Q33681928 | Heterogeneity of familial porphyria cutanea tarda. |
Q41496135 | Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda |
Q62607290 | High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda |
Q72553878 | Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda |
Q44872150 | Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda |
Q44913686 | Incidence of hereditary porphyria cutanea tarda (PCT) in a sample of the Italian population |
Q70899822 | Increased inhibition of hepatic uroporphyrinogen decarboxylase by hexachlorobenzene in male rats given the oestrogenic drugs diethylstilboestrol and chlorotrianisene |
Q36692232 | Isolation and characterization of new porphyrin metabolites in human porphyria cutanea tarda and in rats treated with hexachlorobenzene by HPTLC, HPLC and liquid secondary ion mass spectrometry |
Q36686039 | Isolation, sequencing and expression of cDNA sequences encoding uroporphyrinogen decarboxylase from tobacco and barley. |
Q28576673 | Mechanism of hexachlorobenzene-induced porphyria in rats. Effect of phenobarbitone pretreatment |
Q54788604 | Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: Characterization of four novel mutations |
Q34520576 | Molecular analysis of uroporphyrinogen decarboxylase deficiency in a family with two cases of hepatoerythropoietic porphyria |
Q34649898 | Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene |
Q36267789 | Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias |
Q70072492 | Porphyria cutanea tarda and HLA-linked hemochromatosis |
Q43038650 | Porphyria cutanea tarda and antibodies to hepatitis C virus. |
Q34392355 | Porphyria cutanea tarda and haemochromatosis: a family study |
Q72511186 | Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study |
Q42574912 | Porphyria cutanea tarda and hepatitis C virus infection in a patient with acute liver failure. |
Q49294257 | Porphyria cutanea tarda during maintenance haemodialysis |
Q39729523 | Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases |
Q34097888 | Porphyria cutanea tarda. |
Q70027904 | Porphyria. Basic science aspects |
Q37305931 | Porphyrias and porphyrins |
Q39696618 | Porphyrinurias and occupational disease |
Q71142642 | Prenatal exclusion of congenital erythropoietic porphyria (Günther's disease) in a fetus at risk |
Q35217843 | Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. |
Q41963947 | Purification of uroporphyrinogen decarboxylase from human erythrocytes. Immunochemical evidence for a single protein with decarboxylase activity in human erythrocytes and liver |
Q40150902 | Recent advances in the identification of enzyme deficiencies in the porphyrias |
Q70069371 | Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda |
Q42623529 | Systemic abnormalities in liver disease |
Q40178065 | The Biochemical Diagnosis of the Porphyrias |
Q50986042 | The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland |
Q28579667 | The decrease in uroporphyrinogen decarboxylase activity induced by ethanol predisposes rats to the development of porphyria and accelerates xenobiotic-triggered porphyria, regardless of hepatic damage |
Q70871968 | The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron |
Q41985126 | The effects in vivo of mutationally modified uroporphyrinogen decarboxylase in different hem12 mutants of baker's yeast (Saccharomyces cerevisiae). |
Q69743227 | The effects of ethanol, estrogen, and hexachlorobenzene on the activities of hepatic delta-aminolevulinate synthetase, delta-aminolevulinate dehydratase, and uroporphyrinogen decarboxylase in male rats |
Q45056835 | The genetic basis of porphyria cutanea tarda |
Q72910854 | The porphyrias |
Q40943275 | The porphyrias: a brief overview based on 25 years of experience (1969-1994) by the Department of Dermatology of the Hospital Clinic and Faculty of Medicine of Barcelona, Spain |
Q43522902 | The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection |
Q72922436 | The role of possible membrane damage in porphyria cutanea tarda: A spin label study of rat liver cell membranes |
Q41914010 | Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine |
Q71427038 | Uroporphyria development in cultured chick embryo fibroblasts long-term treated with chloramphenicol and ethidium bromide |
Q40433950 | Uroporphyrinogen decarboxylase |
Q69509293 | [Anesthesia and hepatic porphyria] |
Search more.